Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Racism | 4 | 2025 | 88 | 1.810 |
Why?
|
| Cognitive Dysfunction | 5 | 2020 | 331 | 1.390 |
Why?
|
| Health Behavior | 3 | 2025 | 472 | 1.220 |
Why?
|
| Cardiovascular Diseases | 4 | 2025 | 844 | 1.120 |
Why?
|
| Atherosclerosis | 2 | 2025 | 153 | 1.010 |
Why?
|
| Allostasis | 3 | 2021 | 10 | 0.930 |
Why?
|
| Aging | 7 | 2024 | 744 | 0.920 |
Why?
|
| Stress, Psychological | 3 | 2021 | 474 | 0.870 |
Why?
|
| Coronary Vessels | 2 | 2022 | 120 | 0.810 |
Why?
|
| Cognition | 3 | 2025 | 484 | 0.760 |
Why?
|
| Depression | 2 | 2022 | 908 | 0.750 |
Why?
|
| Dementia | 4 | 2023 | 262 | 0.720 |
Why?
|
| Minority Groups | 2 | 2019 | 140 | 0.700 |
Why?
|
| Blood Pressure | 1 | 2019 | 514 | 0.500 |
Why?
|
| Diet | 1 | 2019 | 527 | 0.460 |
Why?
|
| United States | 11 | 2025 | 7836 | 0.420 |
Why?
|
| Leishmania infantum | 2 | 2023 | 8 | 0.400 |
Why?
|
| Leishmaniasis, Visceral | 2 | 2023 | 14 | 0.390 |
Why?
|
| Humans | 33 | 2025 | 63527 | 0.390 |
Why?
|
| Risk Factors | 8 | 2025 | 5282 | 0.380 |
Why?
|
| Social Determinants of Health | 2 | 2025 | 137 | 0.380 |
Why?
|
| Coinfection | 2 | 2023 | 58 | 0.370 |
Why?
|
| Anxiety | 1 | 2015 | 429 | 0.360 |
Why?
|
| Exercise | 1 | 2019 | 946 | 0.360 |
Why?
|
| DNA Methylation | 2 | 2024 | 292 | 0.350 |
Why?
|
| Male | 20 | 2025 | 29931 | 0.350 |
Why?
|
| Female | 21 | 2025 | 32939 | 0.340 |
Why?
|
| Biomarkers | 3 | 2024 | 1405 | 0.330 |
Why?
|
| Feeding and Eating Disorders | 2 | 2022 | 49 | 0.320 |
Why?
|
| Middle Aged | 10 | 2025 | 17656 | 0.320 |
Why?
|
| Aged, 80 and over | 7 | 2025 | 5468 | 0.320 |
Why?
|
| Aged | 13 | 2025 | 14451 | 0.290 |
Why?
|
| Young Adult | 5 | 2025 | 4714 | 0.260 |
Why?
|
| Narration | 1 | 2025 | 51 | 0.220 |
Why?
|
| Cohort Studies | 4 | 2024 | 2571 | 0.220 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2024 | 38 | 0.210 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2024 | 43 | 0.210 |
Why?
|
| Epigenesis, Genetic | 2 | 2024 | 385 | 0.210 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2023 | 16 | 0.200 |
Why?
|
| Parasites | 1 | 2022 | 16 | 0.190 |
Why?
|
| Health Status Disparities | 1 | 2024 | 143 | 0.190 |
Why?
|
| Alzheimer Disease | 3 | 2014 | 722 | 0.190 |
Why?
|
| Bulimia | 1 | 2022 | 17 | 0.180 |
Why?
|
| Socioeconomic Factors | 2 | 2024 | 784 | 0.180 |
Why?
|
| Coronary Artery Disease | 1 | 2025 | 314 | 0.170 |
Why?
|
| Life Style | 2 | 2022 | 313 | 0.170 |
Why?
|
| Health Promotion | 1 | 2025 | 500 | 0.170 |
Why?
|
| Neuropsychological Tests | 4 | 2015 | 393 | 0.170 |
Why?
|
| Social Segregation | 1 | 2020 | 10 | 0.160 |
Why?
|
| Nursing Homes | 3 | 2020 | 671 | 0.160 |
Why?
|
| Qualitative Research | 1 | 2024 | 705 | 0.160 |
Why?
|
| Cancer Pain | 1 | 2020 | 16 | 0.160 |
Why?
|
| Life Expectancy | 1 | 2019 | 33 | 0.160 |
Why?
|
| Sexual and Gender Minorities | 1 | 2021 | 77 | 0.160 |
Why?
|
| Pain Management | 1 | 2020 | 163 | 0.140 |
Why?
|
| Disease Progression | 4 | 2015 | 1170 | 0.140 |
Why?
|
| Pain | 1 | 2020 | 407 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2015 | 418 | 0.130 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2015 | 390 | 0.130 |
Why?
|
| Students | 1 | 2019 | 219 | 0.130 |
Why?
|
| Proportional Hazards Models | 2 | 2015 | 728 | 0.120 |
Why?
|
| Alcohol Drinking | 1 | 2019 | 314 | 0.120 |
Why?
|
| Quality of Health Care | 1 | 2020 | 519 | 0.120 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 363 | 0.120 |
Why?
|
| Maryland | 1 | 2015 | 35 | 0.120 |
Why?
|
| HIV Infections | 1 | 2022 | 972 | 0.120 |
Why?
|
| Irritable Mood | 1 | 2015 | 16 | 0.120 |
Why?
|
| Psychomotor Agitation | 1 | 2015 | 19 | 0.120 |
Why?
|
| Apathy | 1 | 2015 | 9 | 0.120 |
Why?
|
| Hypertension | 1 | 2020 | 590 | 0.110 |
Why?
|
| Binge-Eating Disorder | 1 | 2014 | 13 | 0.110 |
Why?
|
| Smoking | 1 | 2019 | 863 | 0.100 |
Why?
|
| Longitudinal Studies | 4 | 2024 | 1259 | 0.100 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 158 | 0.100 |
Why?
|
| Quality of Life | 1 | 2020 | 1240 | 0.100 |
Why?
|
| Brazil | 2 | 2023 | 100 | 0.100 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 2463 | 0.100 |
Why?
|
| Adult | 6 | 2025 | 16895 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 172 | 0.090 |
Why?
|
| Atrial Fibrillation | 1 | 2020 | 833 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2013 | 477 | 0.090 |
Why?
|
| Health Status | 1 | 2012 | 443 | 0.080 |
Why?
|
| Neoplasms | 1 | 2020 | 1374 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 2584 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2015 | 2026 | 0.070 |
Why?
|
| Mental Disorders | 1 | 2015 | 794 | 0.070 |
Why?
|
| Child | 3 | 2023 | 4541 | 0.060 |
Why?
|
| Saliva | 1 | 2024 | 103 | 0.050 |
Why?
|
| Crithidia | 1 | 2023 | 2 | 0.050 |
Why?
|
| Focus Groups | 1 | 2024 | 305 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2024 | 223 | 0.050 |
Why?
|
| Creatinine | 1 | 2022 | 133 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2024 | 325 | 0.050 |
Why?
|
| Virulence Factors | 1 | 2022 | 84 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2022 | 123 | 0.050 |
Why?
|
| Sexism | 1 | 2022 | 33 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2022 | 3293 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 359 | 0.040 |
Why?
|
| Genotype | 1 | 2022 | 664 | 0.040 |
Why?
|
| Self Report | 1 | 2023 | 381 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2021 | 142 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2025 | 762 | 0.040 |
Why?
|
| Multimorbidity | 1 | 2020 | 49 | 0.040 |
Why?
|
| Memory | 1 | 2020 | 122 | 0.040 |
Why?
|
| Age Distribution | 1 | 2019 | 257 | 0.040 |
Why?
|
| Longevity | 1 | 2019 | 113 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2019 | 251 | 0.040 |
Why?
|
| Massachusetts | 1 | 2024 | 2072 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2025 | 1641 | 0.030 |
Why?
|
| Pregnancy | 1 | 2024 | 2335 | 0.030 |
Why?
|
| Adolescent | 2 | 2019 | 6259 | 0.030 |
Why?
|
| Age Factors | 1 | 2019 | 1561 | 0.030 |
Why?
|
| Prevalence | 1 | 2019 | 1383 | 0.030 |
Why?
|
| Central Nervous System Stimulants | 1 | 2014 | 64 | 0.030 |
Why?
|
| Risk | 1 | 2015 | 378 | 0.030 |
Why?
|
| ROC Curve | 1 | 2014 | 281 | 0.030 |
Why?
|
| Naproxen | 1 | 2013 | 6 | 0.030 |
Why?
|
| Celecoxib | 1 | 2013 | 13 | 0.030 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2013 | 36 | 0.030 |
Why?
|
| Attention | 1 | 2014 | 147 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2013 | 79 | 0.020 |
Why?
|
| Body Weight | 1 | 2014 | 379 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2013 | 127 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2013 | 308 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 1090 | 0.020 |
Why?
|
| Mental Health | 1 | 2014 | 371 | 0.020 |
Why?
|
| Logistic Models | 1 | 2014 | 1267 | 0.020 |
Why?
|
| Animals | 1 | 2022 | 20715 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2014 | 6619 | 0.010 |
Why?
|